Annual CFO
-$12.05 M
+$2.63 M+17.93%
December 31, 2023
Summary
- As of February 8, 2025, EKSO annual cash flow from operations is -$12.05 million, with the most recent change of +$2.63 million (+17.93%) on December 31, 2023.
- During the last 3 years, EKSO annual CFO has fallen by -$3.30 million (-37.68%).
- EKSO annual CFO is now -100350.00% below its all-time high of -$12.00 thousand, reached on March 1, 2013.
Performance
EKSO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$2.28 M
+$393.00 K+14.72%
September 30, 2024
Summary
- As of February 8, 2025, EKSO quarterly cash flow from operations is -$2.28 million, with the most recent change of +$393.00 thousand (+14.72%) on September 30, 2024.
- Over the past year, EKSO quarterly CFO has increased by +$393.00 thousand (+14.72%).
- EKSO quarterly CFO is now -758900.00% below its all-time high of -$300.00, reached on March 31, 2013.
Performance
EKSO Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$10.00 M
+$1.08 M+9.72%
September 30, 2024
Summary
- As of February 8, 2025, EKSO TTM cash flow from operations is -$10.00 million, with the most recent change of +$1.08 million (+9.72%) on September 30, 2024.
- Over the past year, EKSO TTM CFO has increased by +$1.08 million (+9.72%).
- EKSO TTM CFO is now -116144.19% below its all-time high of -$8600.00, reached on June 30, 2012.
Performance
EKSO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
EKSO Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.9% | +14.7% | +9.7% |
| 3 y3 years | -37.7% | +8.0% | -1.8% |
| 5 y5 years | +45.6% | +50.2% | +36.6% |
EKSO Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -8.1% | +17.9% | -43.8% | +46.4% | at high | +32.0% |
| 5 y | 5-year | -37.7% | +23.6% | -79.3% | +46.4% | -17.5% | +36.6% |
| alltime | all time | <-9999.0% | +61.4% | <-9999.0% | +76.3% | <-9999.0% | +68.0% |
Ekso Bionics Holdings Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.28 M(-14.7%) | -$10.00 M(-9.7%) |
| Jun 2024 | - | -$2.67 M(-23.0%) | -$11.07 M(-2.1%) |
| Mar 2024 | - | -$3.47 M(+118.8%) | -$11.31 M(-6.2%) |
| Dec 2023 | -$12.05 M(-17.9%) | -$1.58 M(-52.8%) | -$12.05 M(-14.6%) |
| Sep 2023 | - | -$3.35 M(+15.5%) | -$14.11 M(+5.7%) |
| Jun 2023 | - | -$2.90 M(-31.1%) | -$13.35 M(-9.2%) |
| Mar 2023 | - | -$4.21 M(+15.6%) | -$14.70 M(+0.1%) |
| Dec 2022 | -$14.69 M(+31.7%) | -$3.64 M(+40.7%) | -$14.69 M(+4.0%) |
| Sep 2022 | - | -$2.59 M(-39.0%) | -$14.12 M(+0.8%) |
| Jun 2022 | - | -$4.25 M(+1.0%) | -$14.00 M(+4.8%) |
| Mar 2022 | - | -$4.21 M(+36.8%) | -$13.36 M(+19.8%) |
| Dec 2021 | -$11.16 M(+27.4%) | -$3.08 M(+24.2%) | -$11.16 M(+13.6%) |
| Sep 2021 | - | -$2.48 M(-31.4%) | -$9.82 M(+14.0%) |
| Jun 2021 | - | -$3.61 M(+80.3%) | -$8.62 M(-4.6%) |
| Mar 2021 | - | -$2.00 M(+14.9%) | -$9.03 M(+3.2%) |
| Dec 2020 | -$8.76 M(-44.5%) | -$1.74 M(+37.0%) | -$8.76 M(+2.9%) |
| Sep 2020 | - | -$1.27 M(-68.4%) | -$8.51 M(-27.9%) |
| Jun 2020 | - | -$4.02 M(+133.6%) | -$11.81 M(-4.1%) |
| Mar 2020 | - | -$1.72 M(+15.2%) | -$12.32 M(-21.9%) |
| Dec 2019 | -$15.77 M(-28.8%) | -$1.50 M(-67.3%) | -$15.77 M(-18.8%) |
| Sep 2019 | - | -$4.57 M(+0.8%) | -$19.43 M(+1.9%) |
| Jun 2019 | - | -$4.53 M(-12.5%) | -$19.07 M(-7.4%) |
| Mar 2019 | - | -$5.18 M(+0.4%) | -$20.60 M(-7.1%) |
| Dec 2018 | -$22.16 M | -$5.15 M(+22.5%) | -$22.16 M(-2.2%) |
| Sep 2018 | - | -$4.21 M(-30.6%) | -$22.66 M(-16.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | -$6.06 M(-10.2%) | -$27.17 M(-11.5%) |
| Mar 2018 | - | -$6.75 M(+19.5%) | -$30.72 M(-1.6%) |
| Dec 2017 | -$31.23 M(+24.9%) | -$5.64 M(-35.3%) | -$31.23 M(+4.0%) |
| Sep 2017 | - | -$8.72 M(-9.2%) | -$30.02 M(+8.3%) |
| Jun 2017 | - | -$9.61 M(+32.4%) | -$27.73 M(+8.9%) |
| Mar 2017 | - | -$7.25 M(+63.3%) | -$25.46 M(+1.9%) |
| Dec 2016 | -$25.00 M(+36.8%) | -$4.44 M(-30.9%) | -$25.00 M(-2.9%) |
| Sep 2016 | - | -$6.43 M(-12.3%) | -$25.74 M(+7.6%) |
| Jun 2016 | - | -$7.33 M(+8.0%) | -$23.93 M(+12.7%) |
| Mar 2016 | - | -$6.79 M(+30.9%) | -$21.23 M(+16.2%) |
| Dec 2015 | -$18.27 M(+21.7%) | -$5.19 M(+12.3%) | -$18.27 M(+15.7%) |
| Sep 2015 | - | -$4.62 M(-0.3%) | -$15.79 M(+7.0%) |
| Jun 2015 | - | -$4.63 M(+21.1%) | -$14.76 M(+11.2%) |
| Mar 2015 | - | -$3.83 M(+41.2%) | -$13.27 M(-11.6%) |
| Dec 2014 | -$15.01 M(>+9900.0%) | -$2.71 M(-24.4%) | -$15.01 M(+22.0%) |
| Sep 2014 | - | -$3.59 M(+14.0%) | -$12.30 M(+41.1%) |
| Jun 2014 | - | -$3.15 M(-43.4%) | -$8.71 M(+55.8%) |
| Mar 2014 | - | -$5.56 M(>+9900.0%) | -$5.59 M(>+9900.0%) |
| Dec 2013 | - | -$1900.00(+26.7%) | -$30.90 K(+0.3%) |
| Sep 2013 | - | -$1500.00(-94.5%) | -$30.80 K(+0.7%) |
| Jun 2013 | - | -$27.20 K(+8966.7%) | -$30.60 K(+155.0%) |
| Mar 2013 | - | -$300.00(-83.3%) | -$12.00 K(+2.6%) |
| Mar 2013 | -$12.00 K | - | - |
| Dec 2012 | - | -$1800.00(+38.5%) | -$11.70 K(+18.2%) |
| Sep 2012 | - | -$1300.00(-84.9%) | -$9900.00(+15.1%) |
| Jun 2012 | - | -$8600.00 | -$8600.00 |
FAQ
- What is Ekso Bionics Holdings annual cash flow from operations?
- What is the all time high annual CFO for Ekso Bionics Holdings?
- What is Ekso Bionics Holdings annual CFO year-on-year change?
- What is Ekso Bionics Holdings quarterly cash flow from operations?
- What is the all time high quarterly CFO for Ekso Bionics Holdings?
- What is Ekso Bionics Holdings quarterly CFO year-on-year change?
- What is Ekso Bionics Holdings TTM cash flow from operations?
- What is the all time high TTM CFO for Ekso Bionics Holdings?
- What is Ekso Bionics Holdings TTM CFO year-on-year change?
What is Ekso Bionics Holdings annual cash flow from operations?
The current annual CFO of EKSO is -$12.05 M
What is the all time high annual CFO for Ekso Bionics Holdings?
Ekso Bionics Holdings all-time high annual cash flow from operations is -$12.00 K
What is Ekso Bionics Holdings annual CFO year-on-year change?
Over the past year, EKSO annual cash flow from operations has changed by +$2.63 M (+17.93%)
What is Ekso Bionics Holdings quarterly cash flow from operations?
The current quarterly CFO of EKSO is -$2.28 M
What is the all time high quarterly CFO for Ekso Bionics Holdings?
Ekso Bionics Holdings all-time high quarterly cash flow from operations is -$300.00
What is Ekso Bionics Holdings quarterly CFO year-on-year change?
Over the past year, EKSO quarterly cash flow from operations has changed by +$393.00 K (+14.72%)
What is Ekso Bionics Holdings TTM cash flow from operations?
The current TTM CFO of EKSO is -$10.00 M
What is the all time high TTM CFO for Ekso Bionics Holdings?
Ekso Bionics Holdings all-time high TTM cash flow from operations is -$8600.00
What is Ekso Bionics Holdings TTM CFO year-on-year change?
Over the past year, EKSO TTM cash flow from operations has changed by +$1.08 M (+9.72%)